Category: COVID-19 TPG Specific Updates

GNO, INC Update – 4/12/2020

Regional Stakeholders, During a crisis, timely, accurate, and actionable information is important.  In order to help you get this information, GNO, Inc. is sending out

Read More

GNO, INC Update – 4/11/2020

Regional Stakeholders, During a crisis, timely, accurate, and actionable information is important.  In order to help you get this information, GNO, Inc. is sending out

Read More

LABEOC Update – 4/10/2020

LABEOC Update – 10 April 2020 As of noon (12:00 PM) today, Louisiana has 19,253 diagnosed cases, 755 deaths and 2,054 patients hospitalized (479 requiring ventilators)associated

Read More

GNO, INC Update – 4/10/2020

Regional Stakeholders, During a crisis, timely, accurate, and actionable information is important.  In order to help you get this information, GNO, Inc. is sending out

Read More

LABEOC Update – 4/9/2020

LABEOC Update – 9 April 2020 As of noon (12:00 PM) today, Louisiana has 18,283 diagnosed cases, 702 deaths and 2,014 patients hospitalized (473 requiring ventilators)associated

Read More

LABEOC Update – 4/8/2020

LABEOC Update – 8 April 2020 As of noon (12:00 PM) today, Louisiana has 17,030 diagnosed cases, 652 deaths and 1,983 patients hospitalized (490 requiring ventilators)associated

Read More

GNO, INC Update – 4/8/2020

Regional Stakeholders, During a crisis, timely, accurate, and actionable information is important.  In order to help you get this information, GNO, Inc. is sending out

Read More

GNO, INC Update – 4/9/2020

Regional Stakeholders, During a crisis, timely, accurate, and actionable information is important.  In order to help you get this information, GNO, Inc. is sending out

Read More

GOHSEP Zoom Update – 4/9/2020

EDO’s, The below notice was produced and approved by ESF-17 (LSP, OTS, and LANG) regarding Zoom Security. We ask that it be disseminated as widely as possible. Please

Read More

LABEOC ISO – 4/7/2020

LABEOC Partners – We are looking for a Louisiana-based manufacturing facility that would be capable of producing a SARS CoV-2 Antibody test that One Milo

Read More